Paolo Vicini
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Biomedical EngineeringGoogle:
"Paolo Vicini"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Yates JWT, Byrne H, Chapman SC, et al. (2020) Opportunities for quantitative translational modelling in Oncology. Clinical Pharmacology and Therapeutics |
Milberg O, Gong C, Jafarnejad M, et al. (2019) A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade. Scientific Reports. 9: 11286 |
Jafarnejad M, Gong C, Gabrielson E, et al. (2019) A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer. The Aaps Journal. 21: 79 |
Wang H, Milberg O, Bartelink IH, et al. (2019) simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model. Royal Society Open Science. 6: 190366 |
Gong C, Anders RA, Zhu Q, et al. (2018) Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors. Frontiers in Oncology. 8: 649 |
Bartelink IH, Jones EF, Shahidi-Latham SK, et al. (2018) Tumor drug penetration measurements could be the neglected piece of the personalized cancer treatment puzzle. Clinical Pharmacology and Therapeutics |
Baverel PG, Dubois VFS, Jin CY, et al. (2017) Population Pharmacokinetics of Durvalumab in Cancer Patients and Association with Longitudinal Biomarkers of Disease Status. Clinical Pharmacology and Therapeutics |
Darwich AS, Ogungbenro K, Vinks AA, et al. (2017) Why has model-informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future. Clinical Pharmacology and Therapeutics |
Milberg O, Gong C, Wang B, et al. (2017) Abstract 4531: Systems pharmacology to predict cellular biomarkers and optimize mono- and combination-therapy regimens: Focusing on immune checkpoint targets PD-1, PD-L1 and CTLA-4 Cancer Research. 77: 4531-4531 |
Spilker ME, Chen X, Visswanathan R, et al. (2016) Found in Translation: Maximizing the Clinical Relevance of Nonclinical Oncology Studies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |